The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4

被引:28
作者
Sheikh, Faruk [1 ]
Dickensheets, Harold [1 ]
Pedras-Vasconcelos, Joao [1 ]
Ramalingam, Thirumalai [2 ]
Helming, Laura [3 ]
Gordon, Siamon [4 ]
Donnelly, Raymond P. [1 ]
机构
[1] US FDA, Div Therapeut Proteins, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[2] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[3] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany
[4] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
关键词
Alternative macrophage activation; Arginase; Interleukin-4; Interleukin-13; receptor-alpha; 1; STAT6; GENE-EXPRESSION; IN-VITRO; DIFFERENTIAL EXPRESSION; CYTOKINE SIGNALING-1; INTERFERON-GAMMA; HUMAN MONOCYTES; MICE LACKING; STAT6; CELLS; TRANSCRIPTION;
D O I
10.1159/000376579
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macrophages coexpress both the interleukin (IL)-2R gamma chain (gamma(c)) and IL-13R alpha 1. These receptor chains can heterodimerize with IL-4R alpha to form type I or type II IL-4 receptor complexes, respectively. We used macrophages derived from Il2rg and Il13ra1 knockout (KO) mice to evaluate the requirements for these receptor chains for induction of the alternative macrophage activation (AMA) pathway by IL-4 and IL-13. Absence of gamma(c) significantly decreased activation of STAT6 by IL-4 but not IL-13. However, although activation of STAT6 by IL-4 was markedly reduced in gamma(c) KO macrophages, it was not abolished, indicating that IL-4 can still signal through type II IL-4 receptors via the IL-13R alpha 1 chain. IL-13 failed to activate STAT6 in macrophages derived from Il13ra1 KO mice; however, these cells remained fully responsive to IL-4. The inability of IL-13 but not IL-4 to signal in Il13ra1(-/-) macrophages correlated with the inability of IL-13 but not IL-4 to induce expression of genes such as Arg1, Retnla and Ccl11 that are characteristically expressed by alternatively activated macrophages. In addition, IL-13 but not IL-4 failed to induce membrane fusion and giant cell formation by Il13ra1 KO macrophages. These findings demonstrate that the IL-13R alpha 1 chain is essential for induction of the AMA pathway by IL-13 but not IL-4. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:494 / 505
页数:12
相关论文
共 47 条
[1]   Mouse macrophage development in the absence of the common gamma chain: Defining receptor complexes responsible for IL-4 and IL-13 signaling [J].
Andersson, A ;
Grunewald, SM ;
Duschl, A ;
Fischer, A ;
DiSanto, JP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (07) :1762-1768
[2]  
BECKMANN MP, 1990, J IMMUNOL, V144, P4212
[3]  
Bogdan C, 1997, J IMMUNOL, V159, P4506
[4]   Suppressor of cytokine signaling-1 attenuates the duration of interferon γ signal transduction in vitro and in vivo [J].
Brysha, M ;
Zhang, JG ;
Bertolino, P ;
Corbin, JE ;
Alexander, WS ;
Nicola, NA ;
Hilton, DJ ;
Starr, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) :22086-22089
[5]   DEFECTIVE LYMPHOID DEVELOPMENT IN MICE LACKING EXPRESSION OF THE COMMON CYTOKINE RECEPTOR-GAMMA CHAIN [J].
CAO, XQ ;
SHORES, EW ;
HULI, J ;
ANVER, MR ;
KELSALL, BL ;
RUSSELL, SM ;
DRAGO, J ;
NOGUCHI, M ;
GRINBERG, A ;
BLOOM, ET ;
PAUL, WE ;
KATZ, SI ;
LOVE, PE ;
LEONARD, WJ .
IMMUNITY, 1995, 2 (03) :223-238
[6]   The role of type 2 innate lymphoid cells in asthma [J].
Chang, Ya-Jen ;
DeKruyff, Rosemarie H. ;
Umetsu, Dale T. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2013, 94 (05) :933-940
[7]  
DeFife KM, 1997, J IMMUNOL, V158, P3385
[8]   Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling [J].
Dickensheets, H. ;
Vazquez, N. ;
Sheikh, F. ;
Gingras, S. ;
Murray, P. J. ;
Ryan, J. J. ;
Donnelly, R. P. .
GENES AND IMMUNITY, 2007, 8 (01) :21-27
[9]   Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression [J].
Dickensheets, HL ;
Venkataraman, C ;
Schindler, U ;
Donnelly, RP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10800-10805
[10]  
DOHERTY TM, 1993, J IMMUNOL, V151, P7151